Searched for
ALCHEMIA
Dr Reddy's buys Intellectual Property Rights for anti-coagulant drug for $17.5 million"Alchemia has received $17.5 million from Dr Reddy's as consideration for the sale. The agreement is effective July, 2015," it added.- Dr Reddy's Laboratories to buy IP rights of fondaparinux for $17.5 millionFondaparinux is a generic version of the anticoagulant drug Arixtra which is indicated for the treatment of deep vein thrombosis (DVT).
- Dr Reddy's Laboratories to launch anti-blood clot drug in CanadaDr Reddy's Laboratories is set to take its complex generic drug Fondaparinux sodium injection to Canada and two other emerging markets.
- Dr Reddy's to launch anti-blood clot drug in CanadaAccording to a statement by Alchemia Ltd, an Australian pharmaceutical company which has marketing tie up with the city-based drug maker.
- Dr Reddy's applies to market fondaparinox sodium in EuropeDr Reddy's Laboratories is set to take its limited-competition drug fondaparinux sodium to the European market.
- Fondaparinux injection issue resolved with USFDA: Dr Reddy's LaboratoriesDr Reddy's Labs has resolved all issues raised by a division of US health regulator over its promotional material for an anti-coagulant inj...
- Dr Reddy's Labs in trouble with US health regulator againDr Reddy's Labs has run into trouble with the US health authorities again, this time for not highlighting important risk information on a p...
- Dr. Reddy's shares slip despite posting better Q1 resultsDr Reddy's Lab yesterday reported its quarterly results with a 20 pc uptick in profits however shares continued its southward journet today...
- Dr Reddy's Labs receives approval to launch Fondaparinux Sodium injectionDRL has received the final approval from USFDA to launch Fondaparinux Sodium injection, used for treating deep vein thrombosis (DVT).
- Dr Reddy's receives US approval for Fondaparinux injectionDRL and Brisbane-based Alchemia Limited today announced that the USFDA has given approval for Fondaparinux Sodium injection.
- Dr Reddy Laboratories sign MoU with Australian pharmaIndian Pharma major Dr Reddy Laboratories signed an agreement with Alchemia, an Australian Pharmaceutical company, for marketing Fondaparin...
- Arcelor Mittal to sell steel unit in PolandArcelor Mittal has decided to sell off a steel unit in Poland. The sale of Huta Bankowa to Alchemia Capital group is the third such sale of...
Load More
